2011
DOI: 10.4155/bio.11.83
|View full text |Cite
|
Sign up to set email alerts
|

Incurred Sample Reanalysis: Different Evaluation Approaches on Data Obtained for Spironolactone and its Active Metabolite Canrenone

Abstract: Different statistical approaches for making data comparisons are discussed and may be successfully applied during reanalysis of samples from a bioequivalence study. Results of the evaluations may differ in accordance with the statistical procedure being applied, thus a definitive conclusion requires consideration of all specific experimental circumstances arising during production of the processed data.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 27 publications
0
8
0
Order By: Relevance
“…The authors believe that a thorough investigation of ISR failures is critical to understanding the nature of the errors (what drug types, matrices, and/or assay conditions) and how the errors can be tightly controlled during study sample analysis to provide accurate and reliable results. Various tools to investigate ISR data have been reported in literature (12,16,18), and some of them have been used in this article to understand the in vivo ISR data.…”
Section: Discussionmentioning
confidence: 99%
“…The authors believe that a thorough investigation of ISR failures is critical to understanding the nature of the errors (what drug types, matrices, and/or assay conditions) and how the errors can be tightly controlled during study sample analysis to provide accurate and reliable results. Various tools to investigate ISR data have been reported in literature (12,16,18), and some of them have been used in this article to understand the in vivo ISR data.…”
Section: Discussionmentioning
confidence: 99%
“…there is no concern associated with AG) appear to assume that an interfering metabolite, if present, is moderately stable, because a typical reference value is established from a sample that is collected without special care, shipped in a frozen state, and measured at a bioanalytical laboratory. A number of case studies typically determined frozen long-term stability [18][19][20][21][22][23][24][25][26], some of which also examined other test items. Test items and study design were surveyed by EBF [27] and GCC [7] and extensively discussed by Yadav et al [28].…”
Section: Discussionmentioning
confidence: 99%
“…Knowing the metabolism is critical to measuring the correct components by the correct procedures [17,18]. A full understanding of the biotransformation also greatly reduces the risk of metabolite interference or conversion to another analyte [19][20][21]. For a xenobiotic drug candidate, interference is more frequently due to a Phase II conjugate such as an N-or O-glucuronide when in-source fragmentation of a co-eluting conjugate can be hidden under the parent peak.…”
Section: Knowing Your Drug's Metabolismmentioning
confidence: 99%